ARCHIVES

Trials Approved by NCI CTEP For the Month of May

This article is from The Cancer Letter archive.

Vol. 35 No. 5 | May 25, 2012

Download PDF Visit The Full Archive

Related Articles

Study Shows MammaPrint Test Can Predict 25-Year Risk Levels

February 28, 2014

Two Second-Line CML Drugs Work Front-Line, Studies Find

January 29, 2010

Letter: Medicare Policy May Delay Access to Cancer Drugs

June 13, 2003

CPRIT Sets Funding Priorities For Rare and Pediatric Cancers

November 14, 2014

Congress Okays NIH Reauthorization, Allows NCI $472 Mil. More

June 12, 1992

NCAB Study Core Guideline Revisions; Final Decision To Await New Division BSC

May 23, 1980